Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

verapamil

verapamil
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Verelan PM CAPSULE, EXTENDED RELEASE, ORAL 100 mg, 200 mg, 300 mg      
Verelan CAPSULE, EXTENDED RELEASE, ORAL 120 mg, 180 mg, 240 mg, 360 mg    
Calan, Isoptin I.V. SOLUTION, INTRAVENOUS 2.5 mg/mL      
Calan SR, Isoptin SR TABLET, EXTENDED RELEASE, ORAL 120 mg, 180 mg, 240 mg      
Covera-HS TABLET, EXTENDED RELEASE, ORAL 180 mg/24 hours, 240 mg/24 hours    
Calan TABLET, ORAL 40 mg, 80 mg, 120 mg      


Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

verapamil (Covera-HS)

  • 180 mg tablet extended release daily
  • 240 mg tablet extended release daily
  • 360 mg tablet extended release daily

verapamil PM (Verelan PM)

  • 200 mg capsule extended release daily
  • 300 mg capsule extended release daily
  • 400 mg capsule extended release daily

verapamil ER (Verelan)

  • 120 mg capsule extended release daily
  • 180 mg capsule extended release daily
  • 240 mg capsule extended release daily
  • 360 mg capsule extended release daily
  • 480 mg capsule extended release daily

verapamil SR (Calan SR, Isoptin SR)

  • 120 mg tablet extended release daily
  • 180 mg tablet extended release daily
  • 240 mg tablet extended release daily
  • 180 mg BID
  • 240 mg BID

Last updated: Sep. 16, 0002







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.